Biotech, Developing & Developed Countries Vaccine Manufacturers COVID-19 Press Briefing - 16 Dec 21

On 16 December 2021, BIO, DCVMN, and IFPMA organized a press briefing: End of year COVID-19 vaccine manufacturing update and challenges for 2022. Speakers included: • Thomas Cueni, Director General, International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) • Dr Michelle McMurry-Heath, President & CEO, Biotechnology Innovation Organization (BIO) • Sai Prasad, Executive Director, Quality Operations, Bharat Biotech, President, Developing Countries Vaccine Manufacturers’ Network (DCVMN) • Rasmus Bech Hansen, CEO & Founder, Airfinity Resources: • IFPMA: www.ifpma.org • IFPMA News Releases: https://www.ifpma.org/resources/news-... • IFPMA COVID-19 Information Hub, with examples of how the biopharmaceutical industry is leading the way in developing vaccines, treatments and diagnostics: https://www.ifpma.org/covid19/ • Full videos of the past IFPMA COVID-19 press briefings:    • COVID-19 media briefings   More about IFPMA: IFPMA represents the research-based pharmaceutical companies and associations across the globe. The research-based pharmaceutical industry’s 2 million employees discover, develop, and deliver medicines and vaccines that improve the life of patients worldwide. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community find solutions that improve global health. Visit our website: www.ifpma.org Follow us on Twitter: @IFPMA Follow us on LinkedIn: /ifpma